Matinas biopharma to participate in the btig virtual biotechnology conference 2023

Bedminster, n.j., aug. 02, 2023 (globe newswire) -- matinas biopharma holdings, inc. (nyse american: mtnb), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (lnc) platform technology, announces that jerome d. jabbour, chief executive officer, will hold meetings with institutional investors during the btig virtual biotechnology conference 2023 being held august 7-8, 2023. the matinas presentation is posted on the investors page of the company's website.
MTNB Ratings Summary
MTNB Quant Ranking